Web Scouter
Back to News
Security News

FDA Approves Extended Dosing Interval for Regeneron’s EYLEA HD (aflibercept)

UnknownApr 15, 2026(27 days ago)

FDA Approves Extended Dosing Interval for Regeneron’s EYLEA HD (aflibercept)

On April 2, 2026, Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration has approved an extension to the dosing intervals for EYLEA HD (aflibercept) patients with wet age-related macular degeneration (wAMD) and diabetic macular edema (DME). ... By: Goodwin

Related News

Deal Reached With Hackers to Delete Data Stolen From the Canvas Educational Platform

Unknown28 minutes ago

West Pharmaceutical Services Hit by Disruptive Ransomware Attack

Unknownabout 1 hour ago

Apple Patches Dozens of Vulnerabilities in macOS, iOS

Unknownabout 1 hour ago

Get Personalized Alerts

Track vendors and receive alerts when security incidents affect your supply chain.

What We Monitor

Security Incidents

Data breaches, ransomware, and unauthorized access

Vulnerabilities

CVEs and vendor security advisories

Compliance Updates

Regulatory changes and certification news

Legal News

Privacy laws and enforcement actions

Vendor Directory

Browse our directory of SaaS vendors with security documentation and compliance information.